⌘K

Home/Filings/4/0001171843-13-000008

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-13-000008

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 12:56 PM ET

Size

5.0 KB

Accession

0001171843-13-000008

Insider Transaction Report

Form 4

Period: 2013-01-01

Capstone Therapeutics Corp.CAPS

HOLLIMAN JOHN M III

DirectorExecutive Chairman

Transactions

Award
Stock Option (Right to Buy)
2013-01-01+10,000→ 785,000 total
Exercise: $0.17From: 2013-01-01Exp: 2023-01-01→ Common Stock (10,000 underlying)

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 12:56 PM ET
Size: 5.0 KB

View on SEC.gov